Clinical trial Recruiting at 5 sites Interventional Ages 21 and up

Comparing two trifocal toric intraocular lenses for cataract surgery.

Official title: A Prospective, Multicenter Clinical Study Comparing Outcomes of Two Trifocal Toric Intraocular Lens

Run by Biotech Healthcare Holding Gmbh · NCT07232615 · Data updated 2026-11-12

This trial will test two different trifocal toric intraocular lenses to see which gives better intermediate-distance vision and satisfaction for adults with cataracts and regular corneal astigmatism.

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment138 (estimated)
SponsorBiotech Healthcare Holding Gmbh
Industry-sponsored
Locations6 sites (Düsseldorf, North Rhine-Westphalia and 5 other locations)
StatusRecruiting
StartedNovember 22, 2021
Main results expectedDecember 2026
Study endsFebruary 2027
Registry record updatedNovember 18, 2025
Trial IDNCT07232615 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 21 with cataract and regular corneal astigmatism between 0.75 and 4.5 D, whose calculated IOL power fits the investigational lenses and who can consent and comply with follow‑up are ideal candidates.

Probably not a fit

Patients with prior intraocular or corneal surgery, irregular astigmatism, active ocular disease in the operative eye, certain systemic conditions, pregnancy or lactation, or those outside the specified astigmatism range are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multi‑site interventional comparison enrolls adults having cataract surgery with regular corneal astigmatism who receive one of two commercially available trifocal toric intraocular lenses (Optiflex TRIO or AcrySof IQ PanOptix). The primary outcome is distance‑corrected intermediate visual acuity, with secondary outcomes including safety measures and patient‑reported satisfaction. Eyes will be evaluated preoperatively and at scheduled postoperative visits to measure visual acuity, refractive outcomes, and adverse events. The trial is conducted at three ophthalmology centers in North Rhine‑Westphalia, Germany.

Why it matters

Potential benefit: If successful, the results could help patients achieve better intermediate and overall vision after cataract surgery and reduce dependence on glasses.

How similar studies have gone: Similar trifocal and toric trifocal lenses, including AcrySof PanOptix variations, have shown improved spectacle independence and good visual outcomes in prior published studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age of patient \>21 Years
2. Patient diagnosed with cataract.
3. Patient must have preoperative regular corneal astigmatism between 0.75 to 4.5 D as per corneal topography or keratometry
4. Calculated IOL power is within the range of investigational IOLs.
5. Patient willing to sign inform consent form.
6. Clear intraocular media other than cataract.
7. Female participants of childbearing potential must be willing to ensure that they use effective contraception during the study.

Exclusion Criteria:

1. Previous intraocular or corneal surgery.
2. Traumatic cataract
3. Pregnancy (as stated by patient) or lactation.
4. Concurrent participation in another drug or device investigation.
5. Irregular astigmatism.
6. Patient receiving chlorquine treatment.
7. Subjects with any systemic disease that could increase operative risk or confound the outcome.
8. Active ocular disease in the operative eye other than cataract.
9. Vulnerable subjects as defined in section 12.3.9.
10. Corneal Astigmatism \> 4.5 D

Where it's running

  • Internationale Innovative Ophthalmochirurgie GbR
    Düsseldorf, North Rhine-Westphalia, Germany
    Recruiting
  • Augentagesklinik
    Greven, North Rhine-Westphalia, Germany
    Recruiting
  • Augentagesklinik
    Rheine, North Rhine-Westphalia, Germany
    Recruiting
  • Dr. Agarwal Eye Hospital
    Chennai, Tamil Nadu, India
    Recruiting
  • Hospital Arruzafa
    Córdoba, Córdoba, Spain
    Recruiting
  • Netradhama Superspeciality Eye Hospital
    Bangalore, Karnatak, India
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.